Market Overview

IDEXX Labs Enters Consent Agreement with FTC Bureau of Competition Staff

Related IDXX
UPDATE: Bank Of America Upgrades Abaxis
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI

Idexx Laboratories, Inc. (NASDAQ: IDXX) and the staff of the Bureau of Competition of the U.S. Federal Trade Commission ("FTC") have signed a Consent Agreement to resolve the FTC's investigation into whether the Company engaged in unfair methods of competition.

Under the Consent Agreement, IDEXX cannot have exclusive distribution agreements with all three of MWI Veterinary Supply, Inc. ("MWI"), Butler Schein Animal Health, and Webster Veterinary. IDEXX may maintain exclusive distribution agreements with two of these three distributors. IDEXX's non-exclusive agreement with MWI, effective January 1, 2013, brings the Company into compliance with the terms of the Consent Agreement. 

The Consent Agreement expressly states that the Company admits no wrongdoing.

Posted-In: News

 

Most Popular

Related Articles (IDXX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters